VG290131
/ Vimgreen Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 26, 2024
A Phase I Study of Single and Multiple Doses of VG290131 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=86 | Recruiting | Sponsor: Zhejiang Vimgreen Pharmaceuticals, Ltd. | Trial completion date: May 2024 ➔ Dec 2024 | Trial primary completion date: Apr 2024 ➔ Dec 2024
Trial completion date • Trial primary completion date
1 to 1
Of
1
Go to page
1